pentobarbital will decrease the extent or outcome of pimavanserin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. Steer clear of coadministration if at all possible. Monitor for lowered pimavanserin efficacy. A rise in pimavanserin dosage may be essential. pentobarbit